Paul J. Maddon is CEO at PROGENICS PHARMACEUTICALS INC (PGNX). They have made 3 open-market trades across 1 company since 2006, most recently 2010-12-01.
CIK 0001250313
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
2 open-market purchases totalling $282K since 2009, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| PGNX | 854,057 | $3.5M |
Shares reported on the most recent Form 4, priced at the 2010-12-01 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| PGNX | BUY | 2010-12-01 | 2010-12-01 | $4.90 | $25K | -27.5% | -3.2% | -3.2% |
| PGNX | BUY | 2010-11-01 | 2010-11-02 | $4.76 | $24K | -27.5% | -3.2% | -3.2% |
| PGNX | BUY | 2010-10-04 | 2010-10-04 | $4.99 | $25K | -27.5% | -3.2% | -3.2% |
| PGNX | BUY | 2010-09-01 | 2010-09-02 | $4.10 | $21K | -27.5% | -3.2% | -3.2% |
| PGNX | BUY | 2010-08-02 | 2010-08-02 | $4.75 | $24K | -27.5% | -3.2% | -3.2% |
| PGNX | BUY | 2010-07-16 | 2010-07-19 | $4.99 | $25K | -27.5% | -3.2% | -3.2% |
| PGNX | BUY | 2010-06-01 | 2010-06-02 | $4.99 | $25K | -27.5% | -3.2% | -3.2% |
| PGNX | BUY | 2010-05-20 | 2010-05-21 | $4.93 | $25K | -27.5% | -3.2% | -3.2% |
| PGNX | BUY | 2009-10-16 | 2009-10-19 | $4.88 | $90K | -27.5% | -3.2% | -3.2% |
| PGNX | SELL · 10b5-1 | 2007-10-15 | 2007-10-17 | $23.49 | $352K | -27.5% | -3.2% | -3.2% |
| PGNX | SELL · 10b5-1 | 2007-10-01 | 2007-10-03 | $22.03 | $264K | -27.5% | -3.2% | -3.2% |
| PGNX | SELL · 10b5-1 | 2007-09-17 | 2007-09-19 | $23.39 | $281K | -27.5% | -3.2% | -3.2% |
| PGNX | SELL · 10b5-1 | 2007-09-04 | 2007-09-06 | $23.77 | $285K | -27.5% | -3.2% | -3.2% |
| PGNX | SELL · 10b5-1 | 2007-08-15 | 2007-08-16 | $23.16 | $278K | -27.5% | -3.2% | -3.2% |
| PGNX | SELL · 10b5-1 | 2007-08-01 | 2007-08-02 | $21.23 | $255K | -27.5% | -3.2% | -3.2% |
| PGNX | SELL · 10b5-1 | 2007-07-16 | 2007-07-18 | $21.46 | $258K | -27.5% | -3.2% | -3.2% |
| PGNX | SELL · 10b5-1 | 2007-07-02 | 2007-07-05 | $21.68 | $260K | -27.5% | -3.2% | -3.2% |
| PGNX | SELL · 10b5-1 | 2007-06-01 | 2007-06-04 | $21.75 | $261K | -27.5% | -3.2% | -3.2% |
| PGNX | SELL · 10b5-1 | 2007-05-15 | 2007-05-16 | $21.90 | $263K | -27.5% | -3.2% | -3.2% |
| PGNX | SELL · 10b5-1 | 2007-05-01 | 2007-05-03 | $25.61 | $307K | -27.5% | -3.2% | -3.2% |
| PGNX | SELL · 10b5-1 | 2007-04-16 | 2007-04-17 | $26.80 | $322K | -27.5% | -3.2% | -3.2% |
| PGNX | SELL · 10b5-1 | 2007-04-02 | 2007-04-04 | $23.85 | $286K | -27.5% | -3.2% | -3.2% |
| PGNX | SELL · 10b5-1 | 2007-03-15 | 2007-03-19 | $22.95 | $275K | -27.5% | -3.2% | -3.2% |
| PGNX | SELL · 10b5-1 | 2007-03-01 | 2007-03-02 | $26.49 | $318K | -27.5% | -3.2% | -3.2% |
| PGNX | SELL · 10b5-1 | 2007-02-15 | 2007-02-20 | $29.89 | $359K | -27.5% | -3.2% | -3.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.